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ABSTRACT:
DEFICIENCY OF RDH10 CAUSES CLEFT SECONDARY PALATE IN MOUSE
Swetha Raja
November 9, 2017
The focus of this project is to understand the role of Retinoic Acid (RA) produced
by RDH10-mediated metabolism of Vitamin A in palate development. For 80 years
now, we have known that dietary restriction of RA/Vitamin A can cause cleft palate
but we have failed to understand how RA deficiency causes cleft palate. Our gap
in knowledge about how RA deficiency causes cleft palate is mainly owing to the
fact that we lack a model system to study such defects. The aim of this thesis
research project was to determine if conditional inactivation of the Vitamin A
metabolic gene Rdh10 in mouse could serve as an experimental model system to
study the etiology of RA deficient cleft palate in mammals. This study examined a
mouse model system in which Rdh10 was conditionally inactivated using a
Tamoxifen-inducible cre-lox system. At embryonic age 16.5 (E16.5), when palate
fusion was complete in control embryos, we observed 44% of the Rdh10
conditional mutant embryos had complete cleft of the secondary palate.
Histological analysis at E12.5 revealed defects in palate shelf morphology in
mutant embryos. Defects at this stage included reduced palate shelf outgrowth
and a lack of groove between the shelf and the body of the maxilla. We used a
v

BrdU assay to label proliferating cells, and identified an increase in cell proliferation
at the bend region in the mutant embryos compared to controls. Using a reporter
mouse strain to detect RA signaling we observed RA signaling within the anterior
palate shelf tissues. In order to understand if the cleft palate seen in Rdh10 mutant
embryos was due to defects intrinsic to the palate or if the clefts were secondary
to abnormalities in development of the mandible or tongue, we isolated and
cultured maxilla from control and mutant embryos. We observed that there was
no significant difference in fusion rate of palate shelves between control and
mutant maxillae cultured ex vivo. In summary, these data demonstrate conditional
inactivation of Rdh10 in mice proves to be an effective experimental model system
to study how deficiency of RA causes cleft palate. Our findings indicate that RA
signaling is active in palate tissue and regulates cell proliferation and palate shelf
morphology. However, we find that the primary defect causing cleft palate in RA
deficient embryos is not intrinsic to the maxilla. This study opens the door for future
investigation to how RA deficiency cause cleft palate by mechanisms extrinsic to
the maxilla.
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CHAPTER 1: INTRODUCTION AND BACKGROUND
1.1 Palate Overview:
In humans and other mammals, the palate forms a mechanical barrier that
anatomically separates the oral cavity from the nasal cavity. This enables proper
breathing and food intake essential for survival. It also plays an important role in
speech and articulation. Structurally, the palate is formed from two distinct
components, the primary and the secondary palate. The part of the palate that is
present anterior to the incisive foramen is the primary palate and the part that is
present posterior to the incisive foramen is the secondary palate (Fig 1).
Embryologically, the primary palate is formed from the frontonasal prominence.
The secondary palate develops from the palatal shelves that arise as medial
outgrowths of the maxillary process. The secondary palate is structurally
composed of the hard palate and the muscular soft palate.
The development of palate is well regulated by genetic and environmental factors.
Any disturbance during the development process of the palate can result in a major
congenital birth defect called cleft palate. This is discussed in the next section.

1

Primary Palate
Incisive foramen
Secondary Palate

Figure 1. Schematic representation of the definitive palate
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1.2 Congenital Birth Defects:
Congenital anomalies, also known as birth defects, are anatomical abnormalities
that occur during the development of a fetus. One in every 33 child born each day
suffer from a congenital defect, which approximates to 120000 babies each year.
One in five children die of birth defects. Even infants who survive birth defects often
face physical, social and psychological challenges (Centers for Disease Control
and Prevention [CDC] 2014).
One of the most common craniofacial birth defect known in humans are orofacial
clefts (Canfield, Honein et al. 2006). Although the incidence of orofacial clefts
varies across different geographic areas and ethnic groups, one child in every 700
suffers from some form of orofacial cleft. Orofacial cleft is a broad terminology that
includes complete midline cleft, cleft lip with or without cleft palate, and cleft of the
secondary palate.
We have several systems of classification of orofacial clefts. The one most
commonly used in clinical scenario is the Veau system. The Veau system classifies
orofacial cleft into 4 groups based on whether the primary and/or secondary
palates are affected (Veau V. Division Palatine. 1931) (Table 1).
For research purposes, we can classify orofacial clefts as syndromic or nonsyndromic clefts. This helps us better understand the functions of genes and other
factors in the development of craniofacial structures and other organs. Although
the majority of cleft lip and palate cases are non-syndromic, cleft lip and palate
have also been reported as a feature of over 300 syndromes.(Marazita 2002). It is
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valuable to note that cleft palate has been associated with Pierre Robin Syndrome
(PRS). PRS is characterized clinically by micrognathia, cleft palate and early
respiratory difficulty caused by glossoptosis. Mouse model of PRS has been
implicated in several gene mutations such as Sox-9, Sox-11(Benko, Fantes et al.
2009, Huang, Yang et al. 2016).
Cleft palate poses severe functional limitations, expensive health care cost and
serious pyscho-social disturbance to children suffering with this defect. Although
we have improved treatment options available to treat cleft palate, our aim as a
researcher is to understand how the palate develops and how its development and
this information can be applied to prevent cleft palate occurrence in the future. One
of the commonly used tools in developmental biology to understand
morphogenesis and development is the mouse embryonic model. The mouse
model closely simulates the development of palate in human embryos. The
development of palate in mouse is reviewed in detail in the next section.

4

Veau Classification of Cleft Palate

Table 1. Classification of cleft palate- The Veau System
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1.3 Development of Palate in Mouse:
The development of the secondary palate is a multi-step process that involves cell
migration, cell differentiation, proliferation, and apoptosis. In mouse embryos, the
development of the secondary palate can be divided into stages of initiation,
vertical growth, medial growth and fusion (Bush and Jiang 2012).
The craniopharyngeal ectoderm and the migratory mesenchymal neural crest cells
together give rise to the maxillary processes(Ferguson 1988). The mouse palate
developmental stages mentioned above begin at embryonic stage 10.5 (E10.5),
identical to the sixth developmental week in humans. At embryonic stage E10.5,
the bilateral maxillary processes begin to fuse with the medial nasal process to
give rise to the upper lip and the primary palate (Gritli-Linde 2007). The
development of the secondary palate begins by E11.5, whereby the growth of the
palatal shelves is initiated as medial outgrowths of the maxillary processes.(Bush
and Jiang 2012). This stage is called initiation. The palatal outgrowths then grow
vertically on either side of the tongue. The next step in palate development is
elevation. Two models have been proposed as mechanisms for palate elevation.
The early model suggest that the palatal shelves elevate by a rotating mechanism
at E14.0 (Ferguson 1988, Gritli-Linde 2007). However, a recent model of palate
development is gaining popularity. Current understanding of literature says that the
elevation of palate shelf is rather more complicated than a simple flip up
mechanism that was widely accepted before. The horizontal palate shelf is formed
as an outgrowth from the side of the vertical palate shelf rather than the rotation
mechanism (Jin, Tan et al. 2010). After palate shelves are horizontally placed, they
6

grow medially towards the midline and the two palatal shelves on either side
contact in the midline at E14.5. The anteromedial boundary of the palatal shelves
fuses with the primary palate. The upper border of the palatal shelves fuse with the
inferior border of the nasal septum (Kauffman 1992).The medial epithelium seam
disintegrates (Gritli-Linde 2007), leading to mesenchymal interaction and fusion of
the palatal shelves.
Even though, the different steps of palate development were established as early
as 1924 (Peter 1924), the regulation of these events and the etiology underlying
cleft palate is still not well understood. The development of the palate is not as
simple as it seems, but rather complex. It is tightly regulated by genetic and
environmental factors. The genes and the environmental factors further cause
intrinsic disruptions within the palate shelf tissues or extrinsic disruptions to
surrounding orofacial structures, resulting in cleft palate(Ferguson 1988).
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DEVELOPMENT OF THE SECONDARY PALATE-MOUSE
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Initiation

PS

Medial growth

Vertical growth

Fusion

Adapted from 2012, Jeffrey O. Bush and Rulang Jiang
Figure 2. Development of the secondary palate in mouse.
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(Used with Permission)

1.4 Factors Causing Cleft Palate
1.4.1 Cleft palate caused by intrinsic or extrinsic defects
Cleft palate can occur as a result of defects that occur within the palate shelf
tissues directly, or by abnormalities of the tongue or mandible that hinder palate
shelf elevation. Disturbances that occur within the palate shelf tissue directly are
known as “intrinsic” defects. Disturbances that result from primary defects in the
tongue or mandible that secondarily result in cleft palate are known as “extrinsic”
defects.
Intrinsic disruptions can affect the initiation, growth, elevation and/or fusion of the
palate shelf tissue. These disruptions can be caused by both genetic and
environmental factors.
Extrinsic disruptions can result from abnormalities of the tongue or mandible that
physically impede the elevation of the palate shelves. During normal palate
development, the descent of the tongue and growth of the mandible downward
happens prior to palate shelf elevation. If the mandible fails to grow to make room
for descent of the tongue, or if the tongue fails to withdraw due to defects in
myogenesis, then palate shelf elevation can be blocked and cleft palate can occur.
It has been published in the literature that mouse mutations in Sox9 or Hoxa2 lead
to cleft palate due to defective mandibular development, or defects in tongue
myogenesis, respectively (Gendron-Maguire, Mallo et al. 1993, Bi, Huang et al.
2001, Mori-Akiyama, Akiyama et al. 2003).
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1.4.2 Cleft palate caused by genetic or environmental factors:
Disturbances in genetic and environmental factors that control palate development
can cause cleft palate.
Gene mutations in transcription factors, growth factors and signaling molecules
have been implicated in cleft palate (Rice, Spencer-Dene et al. 2004, Alappat, and
Zhang et al. 2005). Signaling molecules, such as sonic hedgehog (SHH),
transforming growth factors (TGF), and fibroblast growth factors (FGF) have been
shown to be involved in palate development. Alterations and gene mutations in
these factors have been implicated in cleft palate in mice (Table 2).

In addition to genetic influence on palate development, environmental factors can
also cause cleft palate. Maternal diet or nutrition are known environmental factors
that are linked to palate formation. During the development of the fetus, the
nutritional status of the embryo is dependent on maternal diet, intake, and
metabolism of food. Maternal diet is crucial particularly during the first trimester
when major organs such as brain and heart develop. Both excess and deficiency
of a nutrient could cause craniofacial anomaly. Amongst all nutrients, vitamins are
of particular importance, as they cannot be synthesized within the body. Vitamins
play a crucial role during growth and development and hence are considered as a
vital ingredient of embryonic nutrition. For example, folate deficiency in the mother
can cause neural tube defects and cleft palate in offspring (Wilcox, Lie et al. 2007).

10

Gene
Mutation

Intrinsic/ Extrinsic
Defect

Reference Paper

Tgfβ3

Intrinsic defective in
proliferation.

(Kaartinen, Voncken
et al. 1995, Proetzel,
Pawlowski et al.
1995).

Primary defect in
fusion of palatal
shelves.
Cyp26b1

Intrinsic- Defective
regulation of fgf10

(Okano, Kimura et al.
2012)

Fgf10

Proliferation defect;
Increased Apoptosis;
Defective adhesion
to other structures.

(Rice, Spencer-Dene
et al. 2004, Alappat,
Zhang et al. 2005)

Pdgfc

Intrinsic: Hypoplasia
of Palate Shelves
with vertically
oriented palate
shelves.

(Ding, Wu et al.
2004)

Shh

Defect in proliferation
and apoptosis

(Rice, Spencer-Dene
et al. 2004)

Table 2. Genes implicated in cleft palate in mice.
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1.5 Vitamin A Metabolism:
Vitamin A is a small lipid soluble molecule that forms one of the most essential
maternal nutrients. Liver, carrots and other green leafy vegetables have good
amounts of Vitamin A. Retinoic acid (RA) is the biologically active form of
Vitamin A. RA regulates many aspects of embryogenesis (Clagett-Dame and
Knutson 2011). Hence, knowledge about metabolism of Vitamin A into active RA,
and how RA regulates embryonic morphogenesis of specific tissues, are needed
for establishing a fundamental understanding in developmental biology. This
understanding will prove to be beneficial for future prevention of disease and its
progression.
Vitamin A is converted into RA by a series of enzymatic reactions. The first step in
this process involves the conversion of retinol into intermediate product, retinal.
This conversion is done by two groups of enzymes, the alcohol dehydrogenase
family (ADH) and the short chain dehydrogenase/ reductase family (SDR). For a
very long time, due to ubiquitous expression pattern of the ADH family and
inadequate study techniques, the conversion of retinol to retinal was considered in
essential for embryogenesis. Recently, RDH10 has been shown to be a critical
enzyme in the metabolism of Vitamin A into RA (Sandell, Sanderson et al. 2007,
Sandell, Lynn et al. 2012). Mutants that lack RDH10 cannot metabolize Vitamin A
and

show

drastic

deficiency

in

production

of

RA

that

affects

embryogenesis(Metzler and Sandell 2016). Generally, mutants that show
complete knockout of Rdh10 die as early as E11.5.
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RA has been known to be regulator of proliferation, differentiation, and apoptosis
of cells and has a known role in regulating gene expression (Rhinn and Dolle
2012). RA regulates gene expression by activating nuclear receptors of the retinoic
acid receptors (RAR) that bind to regulatory DNA elements of target genes (RA
Response Elements) (Fig 3).
The regulation of endogenous levels of RA is critical for embryo development.
Both excess RA and insufficient RA result in craniofacial malformations. The
effects of excessive RA have been well studied using mice lacking
cytochrome P450 enzymes, which control RA levels by degrading RA, and by
supplementation of excess RA in maternal diet (Abu-Abed, Dolle et al. 2001, Sakai,
Tokunaga et al. 2001, Okano, Kimura et al. 2012). In contrast, the effects of
reduction in normal endogenous levels of RA is incompletely understood and there
are no published articles put forth so far on this important topic.
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Vitamin A is converted into active form RA
H3C

CH3

H2OH

CH3

all-trans-Retinol
(Vitamin A)

RDH10
H3C

CH3

H
I
C=O

all-trans-Retinal

CH3

H3C

CH3

COOH

Retinoic Acid

CH3

Developmental genes

Sandell Lab
Figure3.Vitamin A Metabolism. This figure demonstrates the enzymatic conversion of Vitamin A
into RA. The first step in this process involves one of the key enzymes in this regulatory pathway,
RDH10. RDH10 aids in oxidation of retinol into its intermediate, retinal. The next step is the
conversion of retinal into RA. RA is the active metabolite of Vitamin A and regulates transcription
of developmental genes, cell differentiation, proliferation, and apoptosis.
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1.6 Perturbations of Vitamin A are Associated with Cleft Palate in Humans
In addition to mouse studies, Vitamin A deficiency or excess has been shown to
be associated with increased incidence of cleft palate in humans. Epidemiological
studies have revealed that maternal diets that are low in Vitamin A show higher
correlation with incidence of orofacial clefts (Krapels, van Rooij et al. 2004).
Interestingly, dietary intake of rich sources vitamin A, for example liver, reduce the
risk of cleft (McKinney, Chowchuen et al. 2013). Children born with clefts also have
reduced serum vitamin A levels (Zhang, Zhou et al. 2014). On the other hand,
increased consumption of Vitamin A or RA supplements have also shown to be
associated with orofacial clefts (McKinney, Chowchuen et al. 2013) (Krapels, van
Rooij et al. 2004).
In summary, both excess and reduced maternal levels of Vitamin A causes cleft
palate in offspring. Since RA signaling is regulated by the metabolism of a nutrient
in the diet, we can intervene this signaling pathway for the purpose of prevention
of cleft palate. The study and understanding of how vitamin A metabolism can be
intervened to provide therapeutic benefits can be done in animal models and the
results may be applied to the prevention of occurrence of cleft palates in humans.
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1.7 Focus of My Thesis Project:
Because Vitamin A and its metabolic products have the potential to influence the
incidence of orofacial clefts, it is important to understand how vitamin A metabolism
and RA signaling regulate the development of the secondary palate. Although the
teratogenic effects of excessive intake of RA have been explored, we have not
been able to understand the role of deficient RA in the development of cleft palate
for over 80 years now due to technical difficulties. Dietary models of Vitamin A/RA
deficiency affect the health of the mother. Complete knock out model of various
enzymes that aid in the metabolism of Vitamin A have early embryonic death even
before the initiation of palate development (Lohnes, Mark et al. 1994, Halilagic,
Ribes et al. 2007). Adding on to the above reasons, we have also not been to
understand the functions of enzymes that aid in the metabolism of Vitamin A until
very recently (Sandell, Sanderson et al. 2007). Hence, to date the effects of
reduced RA in the development of palate remains an unexplored territory in
developmental biology.
To resolve this issue and to understand the role of endogenous RA in the
development of palate, my project at the Sandell lab utilizes a genetic model that
will allow us to cause RA deficiency in a stage specific manner by conditional
inactivation of RDH10, a critical enzyme that catalyzes the first step in the
conversion of Vitamin A into RA. Other lab members have investigated the
efficiency of tamoxifen induced excision of Rdh10. Rdh10 is excised effectively
within 48 hours after administration of tamoxifen at either embryological age E7.5
or E8.5.
16

Using this model system, I would like to answer the following questions:
1. Is Rdh10 required for development of the secondary palate?
2. Does RA signaling occur in the palate?
3. Does RA produced by Rdh10 regulate cell proliferation in the developing
palatal mesenchyme?
4. If Rdh10 inactivation causes cleft palate, is the defect due to intrinsic
mechanism within the palate shelves or extrinsic mechanism due to
abnormality of the tongue or mandible?
My thesis focuses on answering these key questions on the role of endogenous
RA during development of palate.
Over the course of this study, I have identified that conditional inactivation of
Rdh10 is an effective model system to study the effects of RA deficiency in
development of cleft secondary palate. I show that conditional inactivation of
Rdh10 causes cleft palate in mutant embryos. I show that administration of
tamoxifen at different gestational stages yields different percentages of cleft palate,
indicating that Rdh10 function is required at a specific stage of palate development.
I have demonstrated the presence of RA signaling in the palate at E12.5. In
addition, I demonstrate that RDH10/RA deficient palates cultured ex vivo without
the mandible and tongue fuse at the same rate as controls, suggesting that the
primary defect in these mutants is extrinsic to the palate shelves.

17

CHAPTER 2: MATERIALS AND METHODS
2.1 Animals:
All experiments involving mice were performed in accordance to the protocol that
was approved by the institutional animal care and use committee (IACUC) at the
University of Louisville. The approval number for the same is #15190. The day of
vaginal plug was considered E 0.5.
The RARE-Lac Z reporter mouse was used to understand the spatiotemporal
distribution of RA within the palate shelves. These reporter mice were obtained
from Jackson Laboratories (Official Name: Tg (RARE-Hspa1b/ lacZ) 12Jrt).
The Rdh10 flox/flox ERT2 Cre mice B6.129-Gt(ROSA)26Sor tm1(cre/ERT2) Tyj/J
were obtained from the Jackson laboratory (Strain 008463). The Rdh10+/- mice
lines used in this study were generated and maintained as described previously by
(Sandell, Sanderson et al. 2007, Sandell, Lynn et al. 2012).

2.2 Generation of Rdh10 Conditional Mutants
In order to create a timed inactivation of the Rdh10 gene, we crossed Rdh10flox/flox
Ert2Cre2+/+ with Rdh10+/-. This cross produces embryos of two different genotypes,
heterozygous Rdh10flox/+ Ert2Cre embryos, which have one wild type copy of
Rdh10 and serve as controls, and Rdh10flox/- Ert2Cre, which become
Rdh10-/- mutant upon exposure to tamoxifen.
18

Mutant mice experience Rdh10 inactivation upon activation of the Cre
recombinase enzyme. Activation of the Cre recombinase was done by
administration of single dose of Tamoxifen at either E7.5, or E8.5, or E9.5, or
E10.5.
After administration of tamoxifen, pregnant mice were euthanized at E16.5 using
carbon dioxide gas. Following this euthanasia, cervical dislocation was also
performed to verify that that the animal was deceased before we began dissection.
Embryos were harvested and decapitated from the body. Harvested embryos were
transferred to vials containing10Mm PBS (phosphate buffered saline). The vials
were individually labelled and the tails were sent for genotyping. Embryo heads
were fixed in 4% paraformaldehyde (PFA) at 40C for 24-48 hours and then
transferred back to PBS.
For understanding mechanistic role of Rdh10 deficient cleft palate Embryos were
harvested at various palate developmental stages (E12.5, E13.5, E14.5, and E15.5
& E16.5) after administration of tamoxifen at E8.5.
We administered 5mg Tamoxifen and 1 mg progesterone in 250 µL of corn oil by
oral gavage to individual pregnant female mice after successful mating. This
amount of tamoxifen and progesterone was determined empirically.
2.3 Stain for RARE-Lac Z Reporter Activity:
RARE-LAC Z reporter mice were used to show RA signaling in the developing
palate shelves. RARE-lacZ activity was assayed by X-gal staining. For the staining,
we fixed whole embryo or tissue specimens in 2% Paraformaldehyde and 0.2%
19

glutaraldehyde for 60 min on ice. Following fixation, specimens were rinsed and
incubated in Rinse A solution for 30 min at room temperature. The composition of
Rinse A solution is 5 mM EGTA/2 mM MgCl2/PBS pH 7.3 that was either lab mixed
or purchased from Millipore. Specimens were then rinsed and incubated in pre
warmed Rinse B for 15 minutes at 37 °C. Rinse B solution composed of 2 mM
MgCl2/0.01% Sodium deoxycholate/0.02% NP40/PBS pH 7.3 that was either lab
mixed or obtained from Millipore. When specimens were fixed, rinsed, and ready
to be stained, X-gal (Sigma-Aldrich B4252, suspended at 40 mg/ml in Dimethyl
Formamide) was added to Stain Base Solution to a final concentration of 1 mg/ml.
Specimens were incubated in stain solution overnight at 37 °C in the dark. After
staining, specimens were post-fixed in 4% Paraformaldehyde overnight at 4 °C.
For section staining of RARE lacZ embryos, stained whole mount specimens were
equilibrated to paraffin using minimal incubation times in neo-clear xylene
substitute and embedded. After sectioning, slides were de-paraffinized and
counterstained briefly with Nuclear Fast Red.
2.4 Whole Mount Nuclear Fluorescent Imaging:
To analyze morphology of the palate tissue, embryos were collected at embryonic
stage E16.5 and the mandibles were dissected away to aid in visualizing the palate
shelves. Embryo morphology was visualized by staining whole embryos with DAPI
to label all cell nuclei and imaging fluorescent signal. Embryos were fixed in 4%
formalin overnight at 4oC and then stained with 2 µg/ml DAPI in PBS, a protocol
previously described in (Sandell, Kurosaka et al. 2012). Imaging of these embryos
was done using the Leica M165FC Microscope.
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2.5 Fixation and paraffin embedding of samples:
In order to do Hematoxylin and Eosin staining for morphological analysis and Brdu
assay for proliferation, embryo samples were harvested at different stages of
palate development. Head samples were fixed in 4% Paraformaldehyde (PFA) at
4°C on a shaker for 24-48 hours (depending on the age of the embryo). Samples
were then washed in PBS briefly. Samples were then dehydrated through a series
of graded ethanol (EtOH) (IBI Scientific, Biotechnology grade) at room temperature
with shaking in the following sequence: washed in 25% EtOH for 30 minutes, then
50% EtOH for 30 minutes, then 70% EtOH for 30 minutes once. The 70% EtOH
solution was changed and embryos were left in the solution overnight. Following
that, samples were then washed in 95% EtOH for 30 minutes once, then 100%
EtOH for 30 minutes two times. Following ethanol dehydration, the samples were
washed in neoclear: ethanol mixture at 1:1 ratio for 30 minutes on a rocking
platform at room temperature. Samples were then immersed in neoclear for 15
minutes twice. Then, samples were immersed in tissue embedding medium
(Paraplast Xtra, McCormick Scientific) for 45 minutes. The paraffin was changed
after 45 minutes and samples were placed in a vacuum chamber for another 45
minutes. Finally, fixed mouse heads were embedded in an embedding block with
paraffin wax. Serial frontal sections 8μm thick were prepared using the microtome
(Microm HM315).
2.6 Histological Analysis:
For histological analysis, embryos were dissected at desired stages from timed
pregnant mice, fixed in 4% paraformaldehyde (PFA), dehydrated through an
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ethanol series, embedded in paraffin as mentioned in the previous section. Before
proceeding to the staining protocol, samples were first deparaffinized in the oven
at 58°C for 30 min. Following deparaffinization, the samples were then rehydrated
through xylene (Fisher Scientific, Waltham, Massachusetts, USA) and a graded
ethanol series (EtOH) (IBI Scientific, Biotechnology grade) at room temperature in
the following sequence: immerse the slides in xylene for 10 minutes twice, then
100% EtOH for 10 minutes twice, then 95% EtOH for 2 minute once, then 70%
EtOH for 2 minutes once, and finally in PBS for 1 minute twice. Next, slides were
immersed in hematoxylin stain (Modified Harris Hematoxylin, Sigma-54
Aldrich, St. Louis, MO, USA) for 8 minutes. The slides were then placed under
running water for 5 minutes, following which they were transferred to acid alcohol
for 30 seconds. The slides were once again shown in running tap water for 2
minutes and then transferred to lithium carbonate for 45 seconds. The slides were
washed again in running tap water for 5 minutes. Next, the slides were dipped in
80% EtoH 10 times and then stained with eosin for 40 seconds. Slides were
dehydrated through graded ethanol (EtOH) series and xylene at room temperature
in a fume hood in the following sequence: then 95% EtOH for 5 minutes, then
100% EtOH for 10 minutes twice, then Xylene for 10 minutes and then in a new
xylene for 10 minutes. After that sufficient amount of xylene based permount media
was placed on each slide, and a coverslip was mounted. The slides were then
viewed using the Axiocam MRC5 microscope.
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2.7 BrdU Assay
To understand mechanistic role of RA deficiency in cleft palate, we analyzed cell
proliferation by BrdU incorporation, pregnant females at E12.5 were injected BrdU
(100mg/kg, Sigma Aldrich) intraperitoneally. After 3 Hours, the embryos were
harvested, decapitated and the heads were fixed in 4% PFA for 24 hours. The
heads were then dehydrated through series of ethanol changes and embedded in
paraffin for sectioning by routine procedures. For BrdU assay, these sections were
deparaffinized and rehydrated through series of ethanol and PBS. Antigenic heat
retrieval was performed using citric acid buffer solution. A 2L beaker was taken
containing 450 mL of freshly prepared citric acid buffer solution adjusted to a PH
of 6. Temperature of the solution was adjusted to 68 0C. Slides were placed in this
solution for 15 minutes. Following that, the entire apparatus was cooled down on
bench for 15 minutes. Slides were then immersed in PBS briefly. Pretreatment with
2N hydrochloric acid at 370C was then performed for 15-20 minutes in a coplin jar.
The slides were placed in the coplin jar and were washed in PBS twice for 10
minutes each on a rotating platform. After permeabilization, specimens were
blocked in 0.1M Trish Ph7.5, 0.15M NaCl with PE (Perkin-Elmer FP1020) was
done for at least one hour. The sections were then incubated in 1:100 dilutions of
anti-BrdU antibody (ab6326, Abcam) diluted with the same blocking agent
overnight (250 µl of solution per slide). Following primary antibody, samples were
washed using 0.1% Triton in PBS twice for 10 minutes each. Secondary antibody
was then used. The secondary antibody that was used to visualize the
immunoproduct was Alexa Flour 546 Goat anti- rat IgG (Thermo Fisher Scientific)
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diluted 1 to 300 in block and incubated for 60 minutes. Following the secondary
antibody, samples were washed with 0.1% Triton in PBS twice for 15 minutes each
and counter stained with DAPI 1: 1000 dilutions in PBS. The samples were dried
moderately using Kim wipe and cover slipped using 40 µl of Prolong Gold. The
percentage of BrdU positive cells to total mesenchymal cells in a fixed area was
counted in the anterior and mid regions of palate shelves at E12.5. For the analysis
of bend region, the total number of BrdU positive cells was also counted in a fixed
rectangular area. Three samples and six palates were examined in each group
and stage. The percent BrdU positive cells in the palatal mesenchyme of middle
palate region and the BrdU positive cells per fixed box of the anterior palatal bend
region were noted in the controls and the Rdh10 conditional mutants and a
student’s t-test with unequal variance (two tailed) was performed to assess any
significant differences between the control and the Rdh10 conditional mutants.

2.8 Tongue Measurements:
The E14.5 embryonic heads (n=3) for each genotype were fixed in 4% PFA,
embedded in paraffin and were sectioned in the coronal plane at 8 µm thickness.
Control littermates and Rdh10 conditional mutants were processed in parallel and
used for comparison. Identical sections in the mid regions of the palate were
compared between the control and the mutant taken at the same magnification
using the Axiocam MRC5 microscope. Images were collected from the controls
and the mutants and measurements were done using Image J. Prior to measuring,
we standardized the scale to mm. A line was drawn at the base of the tongue from
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one sulcus to another. A perpendicular line was then drawn from the tip of the
tongue to the line previously drawn. This perpendicular representing the height of
tongue was measured and noted down. Statistical analysis was performed using
Excel and a paired t test was performed. Statistical significance was determined
at 90% confidence interval.
2.9 Roller Bottle Culture for Maxillary Explants:
Freshly dissected maxillary explants of E13.5 embryos were cultured as described
previously by Lan et al(Lan, Zhang et al. 2016).
We performed two different sets of culture experiment. During our initial analysis,
three to four maxillary explants were placed in each scintillation vial containing 6ml
BGJb medium (Invitrogen) supplemented with 2.8 mg/ml glutamine, 6mg/ml BSA
and 1% Penicillin and Streptomycin. The bottle was flushed two minutes each day
with a gas mixture (50% O2, 45% N2 and 5% CO2), sealed airtight using a silicone
plug and incubated at 37°C on a Wheaton Mini Bench-Top roller bottle system at
a speed of 25 rpm for three days. A small piece of tissue was taken from each
explant after 3 days for genotyping and explants were fixed individually. For
imaging the palate shelves, these explants were then transferred to 1: 1000 dilution
of DAPI in PBS and imaged using Leica M165FC Microscope. As we cultured 4 to
5 maxillae in the same scintillation vial without knowing the genotyping, we called
this a combo culture.
In single/ monoculture experiment, we identified the mutants based on salivary
gland or lung phenotype and cultured them together. During times when we were
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unable to identify mutants and controls prior to culturing, we cultured single maxilla
individual vials and the bottles were numbered. We number the tail samples from
the embryo in the same way sent them genotyping. We followed the same culture
technique that was followed for the combo culture. Chi Square test was performed
to analyze statistical significance.
2.10 Statistical Analysis
All results were presented as mean ± SEM. All statistical analyses were done using
Excel software. Two-tailed Student’s t tests were used for comparisons between
two groups. P value less than 0.05 was considered significant. For tongue
measurements, P value of less than 0.1 was considered significant.
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CHAPTER 3: RESULTS
3.1 Generation of conditional Rdh10 mutant embryos and heterozygous controls
In order to generate conditional mutants, we paired Rdh10

flox/flox

Ert2Cre2+/+ with

the Rdh10 -/+. The inducible cre-lox system was used to provide timed excision of
the Rdh10 gene. The mutants obtained by the genetic cross (Fig. 4) are the
Rdh10

flox/-Ert2

Cre and the controls are the heterozygous Rdh10

flox/+

Ert2Cre.

This means that the mutants have a normal Rdh10 gene expression until activation
of the Cre recombinase. This activation of cre enzyme is achieved by the
administration of tamoxifen. Upon tamoxifen administration, the Cre that is bound
to the ER receptor in the cytoplasm is released into the nucleus. This causes the
excision of the exon 2 segment of the Rdh10 gene flanked by the LoxP sites.
The excision causes inactivation of the Rdh10 gene (Fig 5).

This genetic cross is highly useful as we obtain both the heterozygous control
embryos and the Rdh10 conditional mutant embryos from the same litter. Based
on our genetic cross, we expect 50% of the embryos from each liter to be controls
and 50% to be mutants. This genetic cross reduces the variability and prevent bias
of the experimental set up. For example with this study design we ensure that
control embryos and the mutant embryos receive the same dose of tamoxifen, at
the same time, and are collected at the same developmental stage. This can only
be achieved when both genotypes can be produced in a single litter.
27

In conclusion, we were successful in creating Rdh10 conditional mutants and these
mutants were used to examine if loss of RDH10 caused cleft palate.

Figure 4. Generation of Rdh10 Conditional Mutants Embryos
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Figure 5. Inducible Cre-Lox system and generation of conditional mutants and controls.
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3.2 Conditional Inactivation of Rdh10 causes Cleft palate
In order to determine if conditional inactivation of Rdh10 causes cleft palate, we
performed a stage specific excision of Rdh10 by tamoxifen induced conditional
inactivation.
Even though we know tamoxifen, induced conditional inactivation of Rdh10 can be
performed, we did not know the optimal timing to administer tamoxifen and how
long it takes to excise Rdh10.

Therefore, we administered a single dose of

tamoxifen to pregnant female mice at four different stages prior to palate formation
and assessed the impact on palate formation in embryos.

Tamoxifen was

administered either at gestational age at E7.5, or E8.5, or E9.5 or E10.5 and
harvested embryos at E16.5 to assess palate formation.
Following euthanasia of the tamoxifen-treated pregnant female mouse, embryos
were isolated, decapitated and fixed in 4% paraformaldehyde. After fixation, the
mandibles were removed from the embryonic heads allowing us to visualize the
palate. Using nuclear florescent imaging technique, we captured and analyzed
images of the palate shelves in control and mutant embryos. 100% of the control
embryos showed normal palate morphology upon administration of tamoxifen at
either E7.5, E8.5, E 9.5, or E10.5 (Fig. 6A). Interestingly, the Rdh10 conditional
mutants showed cleft palate at different stages of tamoxifen administration (Fig 6
B-E).
When tamoxifen was administered at E7.5, 9% of the mutant embryos showed
complete cleft palate (Fig. 6B, Fig. 7). In addition to complete clefts of the
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secondary palate, we also observed 19% of the mutants with minor palate
abnormalities such as unilateral/ bilateral posterior truncation and incomplete cleft
of the secondary palate (Fig. 6D, Fig. 7). In addition to the defects mentioned
above, when tamoxifen was administered at E7.5 we also observed fewer mutants
than heterozygous controls, indicating that inactivation of Rdh10 caused
embryonic lethality. We estimate that loss of Rdh10 by tamoxifen administration at
E7.5 resulted in lethality of 24% of mutant embryos prior to E16.5 (table 3). This is
likely due to the fact that RA produced by RDH10 activity is not only important for
the development of the palate, but also for the development of vital organs such
as the heart. Due to this reason, early knockout of Rdh10 may have caused
embryonic death.
In contrast, when we administered tamoxifen at E8.5, we observed a higher
percentage of palate abnormalities (58%) and we did not see any mutant lethality
(Fig. 7, table 3).Following administration of tamoxifen at E8.5, mutants were
obtained at the expected frequency of 50%, indicating that there was no embryo
lethality at this stage. Of the mutant embryos 44% showed complete cleft of the
secondary palate and an additional 14% showed minor palate abnormalities (Fig.
6E, Fig. 7, table 3).
The frequency of palate abnormalities was reduced when tamoxifen was
administered at later stages. When tamoxifen was administered at E9.5, we
observed 21% of the mutants with complete cleft of the secondary palate (Fig. 7,
table 3). The percentage of minor palate abnormalities was 32%. The frequency
of minor palate abnormalities was higher at the E9.5 tamoxifen stage compared to
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other stages of tamoxifen administration. No mutant lethality was noted at this
stage.
No palate abnormalities were observed in the mutants when tamoxifen was
administered at E10.5 (table 3). We did observe some embryo lethality at this
stage. However, the percentage embryo lethality and phenotype may not be
significant owing to the small sample size analyzed.
From the above results, we can conclude that the highest percentage of cleft palate
with minimal mutant lethality was observed upon administration of tamoxifen at
E8.5. Hence, further experiments to understand the mechanistic role of Rdh10
deficiency in the development of cleft palate was done by administering tamoxifen
at E8.5.
In summary, loss of Rdh10 causes cleft palate. When 100% of the controls show
normal palate phenotype at E16.5, 44% of the mutants show complete cleft palate
when tamoxifen is administered at E8.5. Therefore, we show that conditional
inactivation model serves to be an effective way to understand how RA deficiency
affects palate development
In addition to establishing a model system that will allow us to improve our
knowledge on how RA deficiency affects palate development, the results obtained
from this experiment also hints at the time frame when RA maybe needed during
palate development. Early administration of tamoxifen at E7.5 caused mutant
lethality while later stages of administration (E9.5 and E10.5) showed reduced
frequency of cleft phenotype, suggesting that Rdh10 mediated metabolism of RA
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may be needed during specific time frame at early stages of palate development.
This finding directed our next set of experiments towards understanding the role
of RA in early palate morphogenesis.
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Figure 6. Morphological analysis of Rdh10 mutant maxilla. Nuclear florescent imaging of E16.5
control(A) and mutants (B-E). (B) showing complete cleft of the secondary palate in mutant. (C),
(D), & (E) showing minor palate abnormalities. Arrow in (C) shows a bilateral posterior truncation
seen in the soft palate. Arrow in (D) shows a unilateral posterior truncation seen in the soft palate.
Arrows in (E) show an incomplete posterior cleft extending into the hard and the soft palate.(F-I)
showing a closer version of the defects (B-E)
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Figure 7. Percent cleft palate distribution and embryo viability at different stages of tamoxifen
administration. 24% of mutant lethality is seen when tamoxifen was administered at E7.5.
Tamoxifen administered at stage E8.5 showed maximum percentage of cleft – 59% of the mutants
examined at E8.5 showed some defects in secondary palate formation. Of the 59% 44% of the
mutants showed complete secondary palate cleft and 15% showed minor palate abnormalities. As
we administered tamoxifen later during embryonic development (T9.5, T10.5), we see a fewer
percentage of cleft to almost no palate abnormalities when tamoxifen is administered at E10.5. This
gradual reduction in phenotype with progression in stage of administration likely suggest an early
role of Rdh10 mediated RA during palate morphogenesis.
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Total Number of
embryos
examined

Number of Hets

Number of
Hets
(Expected)

Number of
Mutants

Number of
mutants
(Expected)

E16.5 T7.5

42

26

21

16

21

E16.5 T8.5

48

21

24

27

24

E16.5 T9.5

37

18

19

19

19

E16.5 T10.5

17

11

8

6

8

Table 3. Distribution of embryo genotype that we expected and obtained at different stages of
tamoxifen administration. We note that the total number of mutants that was expected at E7.5 is
more than the mutants obtained. According to our genetic cross, we need to get 50% of
heterozygous controls and mutants per litter. However, since the number of mutants obtained
was less than the expected, early administration of tamoxifen at E7.5 might have caused some
mutant lethality. Even though the number of mutants observed at E10.5 is also less, this may be
due to fewer litters observed at this stage.
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3.3 RA Signaling in the Palate at E12.5:
Previous studies of RA activity in developing facial tissues have not identified
active signaling within the palate. From result 3.2, it is clear that RA is needed for
palate development. In other words, loss of RDH10-mediated RA production leads
to cleft palate. In order for us to understand the possible mechanistic role of RA
during the development of palate, we wanted to see if there is any detectable RA
signaling within the developing palate shelves. The RARE-Lac Z reporter mouse
was used to understand the spatiotemporal distribution of RA within the palate
shelves. The RARE-LacZ reporter mouse line was generated by Rossant et al
(Add reference!),in which bacterial LacZ gene was placed under the RA receptor
element. Detection of the reporter gene expression is identified dark blue X-gal
stainwhich indicates cells that have active RA signaling. In order to examine if RA
signaling activity was present in developing palate shelves we harvested
RARE-LacZ embryos at E12.5 when early palate shelf growth occurs. We exposed
the palate by removing the mandible and tongue and performed X-gal staining.
This helped us capture even the weakest RA signaling within the palate shelves.
The whole mount images of the LacZ stained embryos revealed strong RA
signaling in the developing nasal sinus region and the primary palate. Careful
examination of the secondary palate revealed a small patch of signaling in the
anterior-most region of the developing palate shelves (Fig. 8). The precise tissue
distribution of the RA signaling was analyzed by paraffin sectioning of the wholemount stained heads. Frontal sections were then counter-stained with Nuclear
Fast Red.
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Consistent with previous studies, no RA signaling activity was detected in the
posterior or middle palate shelf tissue (Fig 9 A, B). However, careful histological
analysis reveals for the first time that RA signaling is present in the developing
secondary palate at E12.5. RA signaling was seen in the epithelium of the bend
region of the anterior palate shelf and the sub-nares anterior zone (SNAZ) (Fig 9
C-F). Although RA signaling was detected in the epithelium of the SNAZ and bend
region, no signaling was detected in the middle palate and the posterior palate
regions. We also did not detect any signaling in the mesenchyme of the palate
shelf at any regions at E12.5.
This finding is extremely valuable in our field of study. Not only has there been a
gap in knowledge regarding the role of RA in palate development, but also no
reported finding of RA signaling within the palate shelf tissues (Okano, Kimura et
al. 2012).
Collectively, these data suggest that RA signaling is seen in the developing palate
shelf at an appropriate time to play an important role in its development. This RA
signaling may be an important intrinsic factor essential for normal development of
the secondary palate.
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Figure 8. Activity of RARE LacZ in developing secondary palate. Whole Mount ß galactosidase
staining of developing palate at E12.5 with the tongue and mandible removed. Dark Blue areas
reveal RAR activity (A). We can see strong signaling in the developing primary palate and the
nasal sinus region. The red line depicts the palate shelf outline on the left side. Since signaling in
sinus is very strong, it is difficult to identify signaling in the anterior region of the palate shelf
depicted by the red circle without sectioning.
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Figure 9. Histological sections stained with nuclear fast red showing RARE LacZ activity. Frontal sections
showing the posterior part of the palatal shelf (A), middle part of the palatal shelf(B), anterior part of the
palatal shelf(C) and the sub nares anterior zone(SNAZ) (D) of the developing secondary palate at E12.5
taken at 4X magnification. Although some RA signaling activity is seen the corner of the mouth in the
posterior region and the middle region of the palatal shelves at E12.5, no detectable signaling seen in
the palatal shelf epithelium or mesenchyme in these regions (A&B). E&F are the same sections as C&D
taken at 10X magnification.10X view of the anterior region showing RA activity in the bend region of the
palate (E).10X view of the SNAZ region of the developing secondary palate showing RA signaling activity
within the epithelium of the palate shelf. (F). Arrow indicates RA signaling in the epithelium of developing
palate shelf tissues. No signaling detected in the mesenchyme at this stage. CM- corner of the mouth;
NS- Nasal Sinus; PM- Palatal mesenchyme.
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3.4 Rdh10 conditional mutants not only display intrinsic defects in early palate
morphogenesis, but also extrinsic defects in tongue positioning.
Now that we have a model system that allows us to study the role of endogenous
RA, we can try to understand the underlying mechanisms it regulates in the palate.
Palate development, as described above (Fig. 2), is a sequential process that
occurs beginning early E11.5 up to E16.5. Since we see cleft palate in Rdh10
conditional mutant embryos at E16.5 by whole mount imaging (Fig. 6 B-E), we
examine the palate tissues of control and mutant embryos by histological staining
at E16.5.
Histological sections taken at E16.5 of the heterozygous controls and the Rdh10
conditional mutants is shown in Fig 10 A-D. Inadequate growth and improper
elevation of palate shelf tissue along with abnormal positioning of the tongue are
some of the findings in the mutants compared to the controls. Growth and elevation
of palate shelf tissues are early events that occur during secondary palate
development. The defects seen at E16.5 are defects that must have occurred
during early stages of palate development. These early defects along with early
RA signaling seen at E12.5 (Result 3.2) once again suggest an early role of RA
during palate development. All our previous results have suggested a possible role
of RA in early palate morphogenesis. Therefore, in order to understand the
mechanism of palate defects resulting from loss of Rdh10, we examined embryos
at different early stages of palatogenesis i.e. E12.5, E13.5 and E14.5 after
administration of tamoxifen at gestational stage E8.5.
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Morphological variations observed using hematoxylin and eosin (H&E) staining
revealed abnormalities in the palate shelf tissue of mutant embryos as early as
E12.5. We compared three controls and three mutants at this stage. H& E staining
of the anterior, middle and the posterior region of the palatal shelves revealed
shorter palatal shelves in the mutants compared to the control (Fig. 11 A-F). All the
mutants observed at this stage showed lack of groove between the palate shelf
tissue and the body of the maxilla in the mid sections of the developing secondary
palate (Fig. 11 D). Moreover, the palatal shelf outgrowth in the anterior region was
reduced in the mutants compared to the control (Fig. 11 F).
Morphological abnormalities were also observed in mutant embryos at E13.5.
Mutant embryos examined at E13.5 revealed a sharp bend region (Fig 12)
compared to the more rounded bend morphology of the controls. We examined
three controls and three mutants at this stage and all three mutants revealed this
phenotype.
We also harvested and sectioned embryos at E14.5. Variations in palate shelf
orientation was observed at this stage in both the controls and the mutants. Of the
six controls sectioned, three controls showed palate shelves that had elevated and
contacted in midline, and three showed vertically oriented palate shelves. Of the
six mutants sectioned, two mutants showed horizontally oriented palate shelves
contacting in midline, one showed asymmetric elevation of palate shelf and 3
showed vertical orientation of palate shelves.
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We wanted to compare the tongue height in Rdh10 conditional mutants and the
controls that had a vertically oriented palate shelf at E14.5. We looked at the mid
palate sections from three controls and three mutants. We found that Rdh10
conditional mutants showed taller tongue compared to controls (Fig 13 and table
4). Statistical significance was obtained at p<0.1.
In addition to the taller tongue at E14.5, we also noted abnormal fusion between
the mandible and the palatal shelf in two of the three mutants examined. Abnormal
shelf-to-mandible contact and loss of epithelium in the developing mandible and
palate was noted with mesenchymal cell fusion (Fig.14). Abnormal shelf-tomandible contact may cause cleft palate by preventing the elevation of palate
shelves. However, our mutants that showed such fusion in the posterior region of
the developing palate shelves showed palatal shelves contacting at the midline in
the anterior and middle region. This observation suggest that, abnormal shelfmandible fusion may result in minor palate abnormalities and not be directly
involved in causing cleft palate in Rdh10 conditional mutants.
In summary, defects in early palate morphogenesis are detected in Rdh10
conditional mutant embryos. Abnormalities in palate morphology can be seen as
early as E12.5. Rdh10 mutants show sharp bend regions at E12.5 and taller
tongues and shelf-to-mandible fusion at E14.5. The presence of RA signaling
within palate shelf tissues (Fig. 9) and the defects in early palate shelf morphology
suggest that the loss of Rdh10 could cause cleft palate by a mechanism intrinsic
to the palate shelf tissues. However, we cannot eliminate the fact that we also see
taller tongues and shelf-to-palate fusion in Rdh10 mutants. Taller tongues could
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cause cleft palate by a mechanism extrinsic to the palate shelf tissues if the
abnormal positioning of the tongue interferes with the elevation of palate shelves.
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Figure 10. Morphological and histological comparison of control and Rdh10 conditional
mutant at E16.5. Nuclear florescent image of palate of control (A) and Rdh10 conditional
mutants. (B)The red line on DAPI images (A&B) showing the location of palate of H&E
stained coronal sections from the control (C) and the Rdh10 conditional mutants(D) at
embryonic age E16.5 (D) showing inadequate growth and improper elevation of palate
shelves. Abnormal tongue musculature also seen in the mutants compared to control
littermates.
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Figure 11.Rdh10 conditional mutants showed morphological defects in palate shelves as early
as E12.5. Hematoxylin and Eosin stained coronal sections of E12.5 control and Rdh10 conditional
mutant embryos. (A-F). Shorter palate shelves in posterior region seen in Rdh10 conditional
mutants (B) compared to control littermates (A). Lack of mid palate groove between the palate
shelf and body of maxilla also seen in mutants (D) compared to control(C) in the mid palate
region. Reduced palate shelf outgrowth seen in the Rdh10 conditional mutants (F) compared to
controls in the anterior region of palate shelves. Arrow indicates region of defect.PS- Palatal shelf;
Max- Body of Maxilla
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A

B

Figure 12.Rdh10 conditional mutants display a sharp bend region at E13.5. Coronal sections of
E13.5 showing the posterior palate shelves in the control (A) and Rdh10 Conditional mutants (B)
Arrows indicate the bend region. Three of the three mutants examined showed this abnormality
compared to the control embryos.
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Figure 13.Rdh10 conditional mutants show taller tongue. (A) Shows heterozygous control and (B)
represents Rdh10 conditional mutant. Measurement of tongue height were compared as
demonstrated by the black line in A & B (n=3). Statistical significance is denoted by the * over the
bar graph. (P<0.1)
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Height of Tongue(in mm)
Control 1
0.608
Control 2
0.647
Control 3
0.55
Avg
0.601667
Mutant 1
Mutant 2
Mutant 3
Avg

0.703
0.672
0.697
0.690667

t-Test: Two-Sample Assuming Unequal Variances

Mean
Variance
Observations
Hypothesized Mean
Difference
df
t Stat
P(T<=t) one-tail
t Critical one-tail
P(T<=t) two-tail
t Critical two-tail

Controls Mutants
0.601667 0.690667
0.002382 0.00027
3
3
0
2
-2.99302
0.047925
2.919986
0.09585
4.302653

Table 4. T test table for height of tongue. The first table representing raw data obtained.
Measurements shown are in mm and was obtained using Image J. t test assuming unequal
variance was obtained using Microsoft excel. Statistically significant data was obtained at p<0.1
level.

49

Control

A
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Figure 14.Rdh10 conditional mutations show palate-oral fusion compared to controls at E14.5.
Coronal H& E sections through E14.5 control (A) and Rdh10 Conditional mutant (B) littermates in
the posterior palate shelf region. Arrow indicates the position of the abnormal fusion in mutant.
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3.5 Increased Defects in Proliferation of Palatal Mesenchyme seen at E12.5:
To investigate the intrinsic role of RA in cleft palate, we examined cell turn-over by
BrdU incorporation. We chose to study cell proliferation over other cellular
mechanisms that could be altered because excess RA has been shown to have
an effect on cell proliferation in the palate (Okano, Kimura et al. 2012). We wanted
to see if our Rdh10 conditional mutants showed altered cell proliferation. Because
we observe RARE-LacZ activity within the developing palate at E12.5, we
assessed the regulation of cell proliferation in the mesenchyme of palate shelves
at that stage. Since a clear morphological difference was seen in the anterior and
mid palate regions in the mutants compared to controls, we decided to measure
proliferation in these regions. We therefore administered BrdU to tamoxifentreated pregnant mice at E12.5. Embryos were harvested 3 hours after BrdU
exposure, fixed, sectioned, and immunostained for presence of BrdU incorporated
into DNA.
In order to quantify the percentage of cells within the palate shelves that had
incorporated BrdU into their DNA, fter immunostaining and imaging, we marked
the outline of palate shelf outgrowth in both the controls and the mutants using the
ImageJ software. We then counted the total number of DAPI positive nuclei in the
mesenchyme and the epithelium of the palate shelf and the total number of BrdU
positive cells per palate shelf (Table 5 & 6). The ratio of BrdU positive cells to the
total number of DAPI positive cells was compared between the heterozygous
controls and the Rdh10 conditional mutants in anterior and mid coronal sections
(Fig 15). Even though the palate shelf outgrowth happened to be smaller in the
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conditional mutants with reduced total number of cells, no statistical difference was
noted in percent of BrdU positive cells in the mesenchyme of the palate shelves.
We also wanted to see if there was any difference in proliferation at the bend region
where RA signaling is seen. We therefore outlined a fixed-size box in the bend
region of control and mutant embryo images and counted the total number of BrdU
positive cells per fixed box. The proliferation in the proximal bend region of the
palate shelf was significantly increased in the Rdh10 conditional mutants
compared to their heterozygous control littermates at p<0.05 significance level (Fig
16).
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SNAZ Region
Mesenchyme

Total
Brdu
number Postive
of cells
Cells

Percent of
Brdu
Postive
Cells

Control
1R

118

51

43.220339

Control
1L

167

65

38.9221557

Control
2R

190

84

44.2105263

Control
2L
Control
3R

187

84

44.9197861

201

95

47.2636816

Control
3L

212

105

49.5283019

Avg=

44.6774651

Mutant
1R

108

43

39.8148148

Mutant
1L
Mutant
2R
Mutant
2L
Mutant
3R
Mutant
3L

110

48

43.6363636

74

39

52.7027027

92

36

39.1304348

149

64

42.9530201

103

42

40.776699

Avg=

43.1690058

Table 5. Percentage of BrdU positive proliferating cells in the anterior mesenchyme.
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Mid Palate
Mesenchyme

Total
Brdu
number Positive
of cells
Cells

Percent of
Brdu
Positive
Cells

Control
1R

365

93

25.4794521

Control
1L

289

80

27.6816609

Control
2R

282

74

26.2411348

Control
2L

334

88

26.3473054

Control
3R
Control
3L

296

102

34.4594595

250

74

29.6

Avg=

28.3015021

Mutant
1R

192

94

48.9583333

Mutant
1L

280

70

25

Mutant
2R
Mutant
2L
Mutant
3R
Mutant
3L

284

88

30.9859155

291

75

25.7731959

197

92

46.7005076

198

84

42.4242424

Avg=

36.6403658

Table 6. Percentage of BrdU positive proliferating cells in the mid palate mesenchyme
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t-Test: Two-Sample Assuming Unequal Variances-SNAZ
Mesenchyme

Mean
Variance
Observations
Hypothesized Mean
Difference
df
t Stat
P(T<=t) one-tail
t Critical one-tail
P(T<=t) two-tail
t Critical two-tail

Control
Mutants
44.67747 43.16901
13.14854 24.88805
6
6
0
9
0.599113
0.281936
1.833113
0.563872
2.262157

t-Test: Two-Sample Assuming Unequal Variances- Mid
Palate Mesenchyme

Mean
Variance
Observations
Hypothesized Mean
Difference
df
t Stat
P(T<=t) one-tail
t Critical one-tail
P(T<=t) two-tail
t Critical two-tail

Control
Mutants
28.3015 36.64037
11.20374 114.3917
6
6
0
6
-1.82262
0.059095
1.94318
0.118191
2.446912

Table 7. Analysis of lack of significance of percentage of BrdU-positive proliferating cells in
anterior and mid-palate mesenchyme. Student t test assuming unequal variance was completed
for three samples each from control and Rdh10 conditional mutants. Observations are shown as
six as it includes right and left shelf from three different samples. P values obtained is more than
0.05, allowing us to conclude that there is no difference in percent of BrdU positive cells between
the control and the Rdh10 conditional mutants in both the mid palate and SNAZ mesenchyme.
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t-Test: Two-Sample Assuming Unequal Variances
Total Proliferating Cells in SNAZ mesenchyme
Control
Mutants
Mean
80.66667 45.33333
Variance
389.0667 99.86667
Observations
6
6
Hypothesized Mean
0
Difference
df
7
t Stat
3.914132
P(T<=t) one-tail
0.002896
t Critical one-tail
1.894579
P(T<=t) two-tail
0.005793
t Critical two-tail
2.364624

t-Test: Two-Sample Assuming Unequal Variances
Total Proliferating Cells in Mid-Palate Mesenchyme
Controls Mutants
Mean
85.16667 83.83333
Variance
125.7667 91.36667
Observations
6
6
Hypothesized Mean
0
Difference
df
10
t Stat
0.221642
P(T<=t) one-tail
0.414527
t Critical one-tail
1.812461
P(T<=t) two-tail
0.829054
t Critical two-tail
2.228139

Table 8. Analysis of significant difference seen in the total proliferating cells in the anterior
mesenchyme. No significance in proliferating cells seen in mid palate mesenchyme Student t test
assuming unequal variance was completed for three samples each from control and Rdh10
conditional mutants. Observations are shown as six as it includes right and left shelf from three
different samples. P values obtained is less than 0.05, allowing us to conclude that the total
proliferating cells in the palate mesenchyme at SNAZ region was fewer in mutants compared to
control. However, no difference in total proliferating cells was noted in mid palate mesenchyme.
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Figure 15.Comparison of proliferating cells and percent BrdU positive cells between control
littermates and Rdh10 conditional mutants in the palatal mesenchyme of the SNAZ region and mid
palate region of palate shelves. DAPI images of the coronal sections from the control littermate (A)
and Rdh10 conditional mutant (B) taken in a 4X magnification that were compared in the SNAZ
region. DAPI images of the coronal sections from the control littermate(C) and Rdh10 conditional
mutant (D) taken in a 4X magnification that were compared in the mid palate region. Yellow line
indicates the outer border of palatal shelf up to which cell counting was made. Graphical
representation of the percent BrdU positive cells in these regions in the control and Rdh10
conditional mutants shown in fig (I) Graphical representation of the number of BrdU positive cells
per palate shelf in the SNAZ and mid palate mesenchyme in these regions in the control and Rdh10
conditional mutants shown in fig (J). Three sections from the wild type and the mutant were
compared. P<0.05 was considered statistically significant. Error bard represent Stdev. * indicates
significance. PM- Palatal Mesenchyme.
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B

A

E

C

D

Figure 16.Rdh10 conditional mutants show an increase in cell proliferation at the bend region in
the mesenchyme of anterior palate shelf at E12.5. (A) and (B) showing 4x Hematoxylin and Eosin
coronal section of the anterior region of palate shelf at E12.5. Black box indicates 4x view of
image (C) and (D). (C) and (D) represents immunofluorescence staining. Red cells indicating
BrdU positive cells. Proliferating cells in bend region counted per fixed box as outlined by the
yellow rectangles in (C) and (D). (E) represents the graphical presentation of the values obtained.
* represents statistical significance at p<0.05.
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3.6 Ex-Vivo Culture of Isolated Maxilla Suggest an Extrinsic Role for RDH10
during Palate Development
Although cell proliferation assay suggests an intrinsic defect within the palate shelf
with increased cell proliferation in the bend region in the mutants compared to the
controls, it is possible that the failure of palate shelf elevation could be secondary
to defects in abnormal tongue and mandible. To investigate this possibility, we
performed a 36 hours’ suspension culture of the maxilla with mandible and tongue
removed.
Control and mutant embryos were harvested at E13.5 after administration of
tamoxifen at E8.5. The heads were separated from the body. The maxillae were
isolated from remaining part of the head by removal of the mandible, forebrain,
and hindbrain. The micro dissected maxillary explants were then suspended in
culture containing modified BGJb medium for 3 days as described in chapter 2.
Since we did not know the genotype of the embryos, initial experiments were
carried out by culturing 3 to 4 maxilla’s together in each scintillation vial, and a
small piece of tissue was removed after culture for genotyping purposed. We
named this type of culture as a “combo” culture. The Vials were gassed with 50%
O2, 5% CO2, and balance N2 each day for two minutes. Genotyping was done after
completion of the culture experiment. The maxillae were fixed and imaged using
the pseudo SEM method described previously.
The results that we obtained from the first combo culture is depicted in Fig.17. The
fusion rate of palate shelves observed in the mutants was more than that of the
controls. Interestingly, we observed more fusion in the mutants grown with the
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controls in the same vial. Cleft palate was seen in controls that were grown
together with these mutants. No cleft palate was observed in controls that were
cultured with other control maxillae in the same vial. Moreover, all mutants that
were cultured together in the same vial showed cleft palate. These initial results
led us to speculate that when control maxillae are cultured with mutants, it is
possible that the RA produced in the controls can cross from one tissue to the
other to help in the growth of palate shelves in mutants.
To test this hypothesis, we decided to perform a “monoculture” whereby maxillae
of mutant embryos were cultured in vials separate from controls. Sometimes, we
were able to predict the genotype of the mutant embryos based on their small
salivary gland phenotype or a characteristic branching defect in mutant lungs. In
such cases, 2-4 mutant maxilla were suspended together in each vial, and the
controls in different vials. In other cases, we culture each individual maxilla in an
independent vial. In a total of seven monoculture experiments, the incidence of
cleft palate that we observed in the mutants was 22.83% and that in the controls
was 12.50% (Fig 18). These data indicate that mutant palates fuse at a frequency
similar to controls when cultured ex vivo without mandible and tongue.
In order to determine if the fused mutant cultured maxillae had evidence of sub
mucous cleft or other histological defects, we processed three controls and three
mutants from three different culture experiments for histological examination. On
examination of the H & E stained sections, we observed that of the three-control
culture maxilla, two-showed incomplete fusion with remaining midline epithelial
seam and one showed complete fusion (Fig 19). Compared to controls, two of the
60

three mutants showed complete fusion and one showed incomplete fusion with
remaining midline epithelial seam. Comparing these findings, we can say that no
significant difference in midline fusion was seen in the Rdh10 conditional mutants
compared to the heterozygous controls after 72 hours’ culture.
These results suggest that the cleft of the secondary palate seen in RA deficiency
is predominantly due to an extrinsic defect in either the mandible development or
abnormal positioning of tongue rather than an intrinsic role in palate itself.
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Fusion Rate of Maxillary Explant Combo Culture
100.00%
90.00%
80.00%
70.00%
60.00%
50.00%
40.00%
30.00%
20.00%
10.00%
0.00%
Control

Rdh10 Conditional Mutants

MAXILLARY EXPLANT COMBO CULTURE
Total
Total
Maxilla
Maxilla
Cultured Fused

PERCENT
FUSION

CONTROL

6

3

50%

MUTANTS

6

4

66.67%

Figure 17. Graphical representation of the fusion rates of palate shelves in the controls and the
Rdh10 conditional mutants in combo culture. With our preliminary data, we concluded that the RA
from controls when grown in the same culture bottles likely rescued the cleft palate seen in
mutant maxilla.

62

Fusion Rate of Maxillary Explant
Mono Culture
100.00%
90.00%
80.00%
70.00%
60.00%
50.00%
40.00%
30.00%
20.00%
10.00%
0.00%

87.50%

77.27%

Control

Rdh10 Conditional Mutants

MAXILLARY EXPLANT SINGLE/MONO CULTURE
Total
Maxilla
Cultured

Total
Maxilla
Fused

PERCENT
FUSION

CONTROL

16

14

87.50%

MUTANTS

22

17

77.27%

Figure 18.Graphical representation of the fusion rates of palate shelves in the controls and the
Rdh10 conditional mutants obtained in monoculture. Even though it appears that the fusion rate
of palate shelves in mutants is fewer than the controls, no statistical difference is observed
compared to controls. This data suggests that removal of tongue and the mandible rescues cleft
palate in Rdh10 conditional mutants, suggesting extrinsic role for RA during palate development.
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Figure 19.Comparison of histological sections of controls and Rdh10 conditional mutants after 72
hours in culture. (A) and (B) showing nuclear florescent imaging of the palate shelf. C-F showing
histological coronal paraffin sections of the cultured maxilla. Three controls and three mutant
samples from three litters were sectioned and stained by hematoxylin and eosin staining. One of
the three controls sectioned showed complete fusion (C), two of the mutants showed complete
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fusion (D). Two controls showed incomplete fusion (E) in comparison to one mutant that showed
incomplete fusion with epithelial seam between the two palate shelves. (F). PS- Palatal Shelf; ESEpithelial Seam

65

3.7 Ectopic Fusion in Nasal Region seen in Rdh10 Conditional Mutants:
Previous studies have shown that Rdh10 conditional mutants exhibit choanal
stenosis or nasal obstruction when we administer tamoxifen at gestational age
E7.5(Kurosaka, Wang et al. 2017). The mutants reported in this study were slightly
different in breeding. They contained only one pair of flox allele while our mutants
contain two pair of flox allele. Hence, we could expect the kinetics of tamoxifen
excision to be slightly different in both cases. We still wanted to see if we see any
similar phenotype in our mutants. Hence, we decided to analyze the sections that
were stained by hematoxylin and eosin for nasal obstruction. Although not as
severe as previously reported by Kurosaka et al, we did observe the nasal
obstruction phenotype when we administered tamoxifen at either E7.5 or E8.5. At
E12.5, apart from the abnormalities in palate morphology, we also detected a
shorter, wider and obliterated sinus opening in two of the three mutants in the
SNAZ where RA signaling is seen. Embryos harvested at E13.5 showed an ectopic
fusion between the nasal septum and the medial nasal epithelium. 73% of the
mutants examined at E13.5 and E14.5 showed this phenotype (Fig 20).
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Figure 20.Nasal obstruction and ectopic fusions seen in Rdh10 conditional mutants. Coronal H &
E sections through the nasal region at stages E12.5, E13.5, E14.5, & E15.5 (A-H). Rdh10
conditional mutants show shorter, wider and obliterated sinus at E12.5 (B) compared to controls
(A). At E13.5, controls showed a clear sinus tract(C) while Rdh10 conditional mutants showed
fusion between the developing nasal sinus and the medial nasal epithelium. At E14.5, mutants
showed obliterated nasal sinus region (F) compared to controls at this stage (E). At E15.5, complete
obliteration of the lower region of the nasal sinus area is seen. Arrows and * depicts regions of
ectopic fusion.
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CHAPTER 4: DISCUSSION
The association of cleft palate with lack of Vitamin A/ RA in diet has been known
for 80 years now but the mechanisms underlying this defect is unknown. One of
the main reasons for the gap in knowledge of how deficient RA affects palate
development is due to a lack of a model system to study its function at palate
developmental stages. In this study, we have addressed this major gap in
knowledge of how RA deficiency affects the development of palate by establishing
a model system that will allow us to further investigate the role of RDH10 mediated
metabolism of vitamin A in palate development. We did this by inactivating RDH10,
a critical enzyme that catalyzes the first step in the conversion of Vitamin A into its
active form, RA. We observed 100% of control embryos had fusion of palate shelf
at E16.5, while 44% RA deficient mutant embryos had complete cleft of the
secondary palate.
In our study, administering tamoxifen at different gestational periods before palate
initiation also proved to be useful in understanding the period when endogenous
RA is needed for palate development. Administration of tamoxifen at early
gestational age E7.5 caused higher percentage of mutant lethality and later stages
of administration at E10.5 showed normal phenotype. This observation suggests
that RDH10 mediated metabolism of RA maybe needed during a specific time
frame at early stages of palate development.
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Previous studies show that there is no RA signaling within the developing
palate.(Okano, Kimura et al. 2012). However, for the very first time, using RARELacZ mice, we have shown RA signaling within the developing palate shelves at
embryonic age E12.5. This difference in the result obtained could be due to a
variation in the way the experiment was carried out. Removal of the tongue and
the mandible allowed better penetration of the X-gal staining and capturing most
of the RA activity in the developing palate shelves at E12.5.
The finding that Rdh10 inactivation causes cleft palate and the presence of RA
signaling within the developing palate shelf tissue at E12.5 raised a question of
what mechanisms RA regulates in the developing palate. Interestingly, even
though we detect RA signaling within palate shelf tissues and an increase in cell
proliferation at the bend region in E12.5, the cleft palate seen in RA deficient
mutants was not due to an intrinsic defect in the palate shelf itself. Our study
demonstrates that the cleft palate seen in RA deficiency is secondary to abnormal
tongue and mandible development in Rdh10 mutants. We have come to this
conclusion based on the ex vivo maxillary explant culture experiment and the
measurement of tongue height from histological sections at E14.5. Cleft palate
seen in Rdh10 mutants was rescued upon culturing maxilla independent of tongue
and mandible.
Our data put together provide us with useful insights on the role on endogenous
RA in palate development. Our results demonstrate a predominant non-intrinsic
role of endogenous RA in causing cleft palate in Rdh10 mutants.

70

In contrast to the gap in knowledge of RA deficient cleft palate, the teratogenic
effects of excess RA is well known. From published literature, we know that excess
dosage of RA can also cause cleft palate. Comparing the findings of our study of
RA deficiency with other published studies on RA excess, it is clear that the
mechanisms underlying the two are quite different.
In conclusion, the RA deficient model of cleft palate needs further investigation.
The findings from my thesis work further directs our research work to mandibular
and tongue abnormalities that may be caused due to RA deficiency. Small
mandible, difficulty in respiration due to glossoptosis and cleft palate are features
of a serious syndrome called the Pierre Robin Sequence. The primary data
obtained in my research work suggest a possibility of RA deficiency resembling
the Pierre Robin Sequence. We can confirm this hypothesis by directing future
experiments towards identifying defects in mandibular and tongue development.
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